- 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
[作者:Azzoli, CG; Temin, S; Aliff, T; Baker, S; Brahmer, J; Johnson, DH; Laskin, JL; Masters, G; Milton, D; Nordquist, L; Pao, W; Pfister, DG; Piantadosi, S; Schiller, JH; Smith, R; Smith, TJ; Strawn, JR; Trent, D; Giaccone, G,期刊:Journal of clinical oncology, 页码:3825-3831 , 文章类型: Article,,卷期:2011年29-28]
- Purpose An American Society of Clinical Oncology (ASCO) focused update updates a single recommendation (or subset of recommendations) in advance of a regularly scheduled guideline update. This document updates one recomm...
- American Society of Clinical Oncology Policy Statement: Opportunities in the Patient Protection and Affordable Care Act to Reduce Cancer Care Disparities
[作者:Moy, B; Polite, BN; Halpern, MT; Stranne, SK; Winer, EP; Wollins, DS; Newman, LA,期刊:Journal of clinical oncology, 页码:3816-3824 , 文章类型: Article,,卷期:2011年29-28]
- Patients in specific vulnerable population groups suffer disproportionately from cancer. The elimination of cancer disparities is critically important for lessening the burden of cancer. The Patient Protection and Afford...
- Association Between Vitamin D and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies
[作者:Ma, YL; Zhang, P; Wang, F; Yang, JJ; Liu, ZH; Qin, HL,期刊:Journal of clinical oncology, 页码:3775-3782 , 文章类型: Review,,卷期:2011年29-28]
- Purpose To conduct a systematic review of prospective studies assessing the association of vitamin D intake or blood levels of 25-hydroxyvitamin D [25(OH)D] with the risk of colorectal cancer using meta-analysis. Methods...
- Bevacizumab-Induced Reversible Posterior Leukoencephalopathy Syndrome and Successful Retreatment in a Patient With Glioblastoma
[作者:Lou, E; Turner, S; Sumrall, A; Reardon, DA; Desjardins, A; Peters, KB; Sampson, JH; Friedman, HS; Vredenburgh, JJ,期刊:Journal of clinical oncology, 页码:E739-E742 , 文章类型: Editorial Material,,卷期:2011年29-28]
-
- Matrix Metalloproteinase-3 Producing Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Associated With Rheumatoid Arthritis
[作者:Nakayama-Ichiyama, S; Yokote, T; Hiraoka, N; Iwaki, K; Takayama, A; Hirata, Y; Miyoshi, T; Oka, S; Akioka, T; Makino, S; Tsuji, M; Hanafusa, T,期刊:Journal of clinical oncology, 页码:E731-E732 , 文章类型: Editorial Material,,卷期:2011年29-28]
-
- Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors
[作者:Paz-Ares, LG; Gomez-Roca, C; Delord, JP; Cervantes, A; Markman, B; Corral, J; Soria, JC; Berge, Y; Roda, D; Russell-Yarde, F; Hollingsworth, S; Baselga, J; Umana, P; Manenti, L; Tabernero, J,期刊:Journal of clinical oncology, 页码:3783-3790 , 文章类型: Article,,卷期:2011年29-28]
- Purpose We conducted a phase I dose-escalation study to characterize the safety, efficacy, pharmacokinetic (PK), and pharmacodynamic properties of RG7160 (GA201), a humanized and glycoengineered immunoglobulin G(1) anti-...
- Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
[作者:Yothers, G; O'Connell, MJ; Allegra, CJ; Kuebler, JP; Colangelo, LH; Petrelli, NJ; Wolmark, N,期刊:Journal of clinical oncology, 页码:3768-3774 , 文章类型: Article,,卷期:2011年29-28]
- Purpose The National Surgical Adjuvant Breast and Bowel Project (NSABP) C-07 trial demonstrated that the addition of oxaliplatin to fluorouracil plus leucovorin (FULV) improved disease-free survival (DFS) in patients wit...
- Magnetic Resonance Imaging-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience
[作者:Patel, UB; Taylor, F; Blomqvist, L; George, C; Evans, H; Tekkis, P; Quirke, P; Sebag-Montefiore, D; Moran, B; Heald, R; Guthrie, A; Bees, N; Swift, I; Pennert, K; Brown, G,期刊:Journal of clinical oncology, 页码:3753-3760 , 文章类型: Article,,卷期:2011年29-28]
- Purpose To assess magnetic resonance imaging (MRI) and pathologic staging after neoadjuvant therapy for rectal cancer in a prospectively enrolled, multicenter study. Methods In a prospective cohort study, 111 patients wh...
- Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience
[作者:Arun, B; Bayraktar, S; Liu, DD; Barrera, AMG; Atchley, D; Pusztai, L; Litton, JK; Valero, V; Meric-Bernstam, F; Hortobagyi, GN; Albarracin, C,期刊:Journal of clinical oncology, 页码:3739-3746 , 文章类型: Article,,卷期:2011年29-28]
- Purpose To compare the pathologic complete response (pCR) rate and relapse-free survival (RFS) and overall survival (OS) after neoadjuvant systemic chemotherapy (NST) in patients with breast cancer with and without delet...
- Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
[作者:Cybulski, C; Wokolorczyk, D; Jakubowska, A; Huzarski, T; Byrski, T; Gronwald, J; Masojc, B; Debniak, T; Gorski, B; Blecharz, P; Narod, SA; Lubinski, J,期刊:Journal of clinical oncology, 页码:3747-3752 , 文章类型: Article,,卷期:2011年29-28]
- Purpose To estimate the risk of breast cancer in a woman who has a CHEK2 mutation depending on her family history of breast cancer. Patients and Methods Seven thousand four hundred ninety-four BRCA1 mutation-negative pat...
|